| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| metelimumab | tgf-beta receptor type i | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Systemic Scleroderma[MeSHID:D012595] Scleroderma[MeSHID:D012594] |
4.55 | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||